FDA Drug Application (020758) for AVALIDE by SANOFI AVENTIS US

Back to FDA Applications sponsored by SANOFI AVENTIS US

Application Number020758
Product Number001
FormTABLET;ORAL
Dosage12.5MG;75MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameAVALIDE
Active IngredientHYDROCHLOROTHIAZIDE; IRBESARTAN

Active IngredientCount
List of drugs with Active Ingredient HYDROCHLOROTHIAZIDE122
List of drugs with Active Ingredient IRBESARTAN7


Back to FDA Applications sponsored by SANOFI AVENTIS US